126 related articles for article (PubMed ID: 8832398)
21. The localization and activity of cAMP-dependent protein kinase affect cell cycle progression in thyroid cells.
Feliciello A; Gallo A; Mele E; Porcellini A; Troncone G; Garbi C; Gottesman ME; Avvedimento EV
J Biol Chem; 2000 Jan; 275(1):303-11. PubMed ID: 10617619
[TBL] [Abstract][Full Text] [Related]
22. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta.
Reynisdóttir I; Polyak K; Iavarone A; Massagué J
Genes Dev; 1995 Aug; 9(15):1831-45. PubMed ID: 7649471
[TBL] [Abstract][Full Text] [Related]
23. Expression of p27Kip1 in osteoblast-like cells during differentiation with parathyroid hormone.
Onishi T; Hruska K
Endocrinology; 1997 May; 138(5):1995-2004. PubMed ID: 9112398
[TBL] [Abstract][Full Text] [Related]
24. Limiting amounts of p27Kip1 correlates with constitutive activation of cyclin E-CDK2 complex in HTLV-I-transformed T-cells.
Cereseto A; Washington Parks R; Rivadeneira E; Franchini G
Oncogene; 1999 Apr; 18(15):2441-50. PubMed ID: 10229195
[TBL] [Abstract][Full Text] [Related]
25. TSH and cAMP do not signal mitogenesis through Ras activation.
Van Keymeulen A; Roger PP; Dumont JE; Dremier S
Biochem Biophys Res Commun; 2000 Jun; 273(1):154-8. PubMed ID: 10873578
[TBL] [Abstract][Full Text] [Related]
26. Cyclin D1 expression is a major target of the cAMP-induced inhibition of cell cycle entry in fibroblasts.
L'Allemain G; Lavoie JN; Rivard N; Baldin V; Pouyssegur J
Oncogene; 1997 Apr; 14(16):1981-90. PubMed ID: 9150365
[TBL] [Abstract][Full Text] [Related]
27. The cyclin-dependent kinase inhibitor p27Kip1 is localized to the cytosol in Swiss/3T3 cells.
Wang G; Miskimins R; Miskimins WK
Oncogene; 1999 Sep; 18(37):5204-10. PubMed ID: 10498870
[TBL] [Abstract][Full Text] [Related]
28. Oncostatin M and interleukin 6 inhibit cell cycle progression by prevention of p27kip1 degradation in HepG2 cells.
Klausen P; Pedersen L; Jurlander J; Baumann H
Oncogene; 2000 Jul; 19(32):3675-83. PubMed ID: 10951574
[TBL] [Abstract][Full Text] [Related]
29. Constitutive overexpression of cyclin D1 in human breast epithelial cells does not prevent G1 arrest induced by deprivation of epidermal growth factor.
Chou JL; Fan Z; DeBlasio T; Koff A; Rosen N; Mendelsohn J
Breast Cancer Res Treat; 1999 Jun; 55(3):267-83. PubMed ID: 10517171
[TBL] [Abstract][Full Text] [Related]
30. Involvement of p27Kip1 in the G1- and S/G2-phase lengthening mediated by glucocorticoids in normal human lymphocytes.
Baghdassarian N; Peiretti A; Devaux E; Bryon PA; Ffrench M
Cell Growth Differ; 1999 Jun; 10(6):405-12. PubMed ID: 10392902
[TBL] [Abstract][Full Text] [Related]
31. Somatostatin is expressed in FRTL-5 thyroid cells and prevents thyrotropin-mediated down-regulation of the cyclin-dependent kinase inhibitor p27kip1.
Medina DL; Velasco JA; Santisteban P
Endocrinology; 1999 Jan; 140(1):87-95. PubMed ID: 9886811
[TBL] [Abstract][Full Text] [Related]
32. Mutual antagonistic interactions between the thyrotropin (adenosine 3',5'-monophosphate) and protein kinase C/epidermal growth factor (tyrosine kinase) pathways in cell proliferation and differentiation of cultured human thyroid follicles.
Kraiem Z; Sadeh O; Yosef M; Aharon A
Endocrinology; 1995 Feb; 136(2):585-90. PubMed ID: 7835292
[TBL] [Abstract][Full Text] [Related]
33. Differentiation expression during proliferative activity induced through different pathways: in situ hybridization study of thyroglobulin gene expression in thyroid epithelial cells.
Pohl V; Roger PP; Christophe D; Pattyn G; Vassart G; Dumont JE
J Cell Biol; 1990 Aug; 111(2):663-72. PubMed ID: 2199463
[TBL] [Abstract][Full Text] [Related]
34. [New regulation mechanisms of cell cycle shown by analysis of thyroid cell proliferation stimulated by TSH and cyclic AMP].
Roger P
Bull Mem Acad R Med Belg; 2004; 159(5-6):396-405. PubMed ID: 15693550
[TBL] [Abstract][Full Text] [Related]
35. cAMP inhibits linoleic acid-induced growth by antagonizing p27(kip1) depletion, but not interfering with the extracellular signal-regulated kinase or AP-1 activities.
Hu ZY; Madamanchi NR; Rao GN
Biochim Biophys Acta; 1998 Oct; 1405(1-3):139-46. PubMed ID: 9784625
[TBL] [Abstract][Full Text] [Related]
36. cAMP-dependent activation of mammalian target of rapamycin (mTOR) in thyroid cells. Implication in mitogenesis and activation of CDK4.
Blancquaert S; Wang L; Paternot S; Coulonval K; Dumont JE; Harris TE; Roger PP
Mol Endocrinol; 2010 Jul; 24(7):1453-68. PubMed ID: 20484410
[TBL] [Abstract][Full Text] [Related]
37. Respective roles of carbamylcholine and cyclic adenosine monophosphate in their synergistic regulation of cell cycle in thyroid primary cultures.
Van Keymeulen A; Deleu S; Bartek J; Dumont JE; Roger PP
Endocrinology; 2001 Mar; 142(3):1251-9. PubMed ID: 11181542
[TBL] [Abstract][Full Text] [Related]
38. Involvement of p27KIP1 in G1 arrest mediated by an anti-epidermal growth factor receptor monoclonal antibody.
Wu X; Rubin M; Fan Z; DeBlasio T; Soos T; Koff A; Mendelsohn J
Oncogene; 1996 Apr; 12(7):1397-403. PubMed ID: 8622855
[TBL] [Abstract][Full Text] [Related]
39. Differential expression of the cyclin-dependent kinase inhibitor P27 in primary hepatocytes in early-mid G1 and G1/S transitions.
McIntyre M; Desdouets C; Sénamaud-Beaufort C; Laurent-Winter C; Lamas E; Bréchot C
Oncogene; 1999 Aug; 18(32):4577-85. PubMed ID: 10467402
[TBL] [Abstract][Full Text] [Related]
40. Differential control of cyclins D1 and D3 and the cdk inhibitor p27Kip1 by diverse signalling pathways in Swiss 3T3 cells.
Mann DJ; Higgins T; Jones NC; Rozengurt E
Oncogene; 1997 Apr; 14(15):1759-66. PubMed ID: 9150381
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
